Literature DB >> 19517217

Calcification capacity of porous pHEMA-TiO₂ composite hydrogels.

Chao Li1, Yu-Feng Zheng, Xia Lou.   

Abstract

Many investigations have been attempted to promote calcification of synthetic polymers for applications as orthopaedic and dental implants. In this study, novel titanium dioxide (TiO(2)) reinforced porous poly(2-hydroxyethyl methacrylate) (pHEMA) hydrogels were synthesized. Calcification capacity of the composite polymers was examined using light microscopy, scanning electron microscopy and Fourier transform infrared spectroscopy after incubation of the materials in a simulated body fluid up to 53 days. Mechanical strength, porosity and in vitro cytotoxicity were also investigated. Calcification capacity of porous pHEMA was significantly enhanced by the addition of TiO(2) particulates. Infiltration of calcium phosphate, up to 1000 mum, was observed. The diffusion capacity of calcium ions was affected by the porosity and the interconnectivity of pores in the hydrogel polymers which were influenced by the presence of TiO(2) and the monomer concentration. Cell viability tests indicated that porous hydrogels containing 7.5% TiO(2) were not toxic to 3T3 fibroblast cells. These results demonstrate that incorporating TiO(2) nanoparticulates can promote enhanced formation of calcium phosphate whilst maintaining the porosity and interconnectivity of the hydrogel polymers and would be very useful for the development of orthopaedic tissue engineering scaffolds.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19517217     DOI: 10.1007/s10856-009-3793-2

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  16 in total

1.  Development and clinical assessment of an artificial cornea.

Authors:  C Hicks; G Crawford; T Chirila; S Wiffen; S Vijayasekaran; X Lou; J Fitton; M Maley; A Clayton; P Dalton; S Platten; B Ziegelaar; Y Hong; A Russo; I Constable
Journal:  Prog Retin Eye Res       Date:  2000-03       Impact factor: 21.198

Review 2.  Contact lens deposits and spoilage: identification and management.

Authors:  R C Tripathi; B J Tripathi; R A Silverman; G N Rao
Journal:  Int Ophthalmol Clin       Date:  1991

3.  Increased osteoblast functions among nanophase titania/poly(lactide-co-glycolide) composites of the highest nanometer surface roughness.

Authors:  Huinan Liu; Elliott B Slamovich; Thomas J Webster
Journal:  J Biomed Mater Res A       Date:  2006-09-15       Impact factor: 4.396

Review 4.  How useful is SBF in predicting in vivo bone bioactivity?

Authors:  Tadashi Kokubo; Hiroaki Takadama
Journal:  Biomaterials       Date:  2006-01-31       Impact factor: 12.479

Review 5.  Studies of the ocular compatibility of hydrogels. A review of the clinical manifestations of spoilation.

Authors:  R W Bowers; B J Tighe
Journal:  Biomaterials       Date:  1987-03       Impact factor: 12.479

6.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

7.  The Chirila Keratoprosthesis: phase I human clinical trial.

Authors:  Geoffrey J Crawford; Celia R Hicks; Xia Lou; Sarojini Vijayasekaran; Donald Tan; Bridget Mulholland; Traian V Chirila; Ian J Constable
Journal:  Ophthalmology       Date:  2002-05       Impact factor: 12.079

8.  Morphological and topographic effects on calcification tendency of pHEMA hydrogels.

Authors:  Xia Lou; Sarojini Vijayasekaran; Runi Sugiharti; Terry Robertson
Journal:  Biomaterials       Date:  2005-04-25       Impact factor: 12.479

9.  Effect of phosphate functional groups on the calcification capacity of acrylic hydrogels.

Authors:  Traian V Chirila; David J T Hill; Andrew K Whittaker; Anne Kemp
Journal:  Acta Biomater       Date:  2006-10-30       Impact factor: 8.947

10.  Altered responses of chondrocytes to nanophase PLGA/nanophase titania composites.

Authors:  Jennifer K Savaiano; Thomas J Webster
Journal:  Biomaterials       Date:  2004 Mar-Apr       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.